These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 27281940)
1. [Immunotherapy for brain tumors: obstacles and perspectives]. Migliorini D; Dietrich PY Rev Med Suisse; 2016 Apr; 12(516):828-31. PubMed ID: 27281940 [TBL] [Abstract][Full Text] [Related]
2. Prospects of immune checkpoint modulators in the treatment of glioblastoma. Preusser M; Lim M; Hafler DA; Reardon DA; Sampson JH Nat Rev Neurol; 2015 Sep; 11(9):504-14. PubMed ID: 26260659 [TBL] [Abstract][Full Text] [Related]
3. The Safety of available immunotherapy for the treatment of glioblastoma. Farber SH; Elsamadicy AA; Atik AF; Suryadevara CM; Chongsathidkiet P; Fecci PE; Sampson JH Expert Opin Drug Saf; 2017 Mar; 16(3):277-287. PubMed ID: 27989218 [TBL] [Abstract][Full Text] [Related]
4. [Targeted therapy in glioblastoma: update and perspectives]. Idbaih A; Duran-Peña A; Alentorn A Bull Acad Natl Med; 2015 Nov; 199(8-9):1323-1329. PubMed ID: 29874421 [TBL] [Abstract][Full Text] [Related]
6. Recent advances in therapy for glioblastoma. Clarke J; Butowski N; Chang S Arch Neurol; 2010 Mar; 67(3):279-83. PubMed ID: 20212224 [TBL] [Abstract][Full Text] [Related]
7. Immunotherapy for the treatment of glioblastoma. Thomas AA; Ernstoff MS; Fadul CE Cancer J; 2012; 18(1):59-68. PubMed ID: 22290259 [TBL] [Abstract][Full Text] [Related]
8. The progress of immunotherapy for glioblastoma. Zhou Q; Wang Y; Ma W Hum Vaccin Immunother; 2015; 11(11):2654-8. PubMed ID: 26308501 [TBL] [Abstract][Full Text] [Related]
9. Novel mechanisms and approaches in immunotherapy for brain tumors. Finocchiaro G; Pellegatta S Discov Med; 2015; 20(108):7-15. PubMed ID: 26321082 [TBL] [Abstract][Full Text] [Related]
10. Achieving efficacious immunotherapy for patients with glioblastoma. Young JS Expert Rev Anticancer Ther; 2020 Nov; 20(11):909-911. PubMed ID: 32852237 [No Abstract] [Full Text] [Related]
11. Immunotherapy in human glioblastoma. Szabo AT; Carpentier AF Rev Neurol (Paris); 2011 Oct; 167(10):668-72. PubMed ID: 21885075 [TBL] [Abstract][Full Text] [Related]
12. Immunotherapy for Neuro-Oncology. Majd N; Dasgupta P; de Groot J Adv Exp Med Biol; 2020; 1244():183-203. PubMed ID: 32301015 [TBL] [Abstract][Full Text] [Related]
13. Combining immunotherapy with radiation for the treatment of glioblastoma. Chow KK; Hara W; Lim M; Li G J Neurooncol; 2015 Jul; 123(3):459-64. PubMed ID: 25877468 [TBL] [Abstract][Full Text] [Related]
14. Current State of Immune-Based Therapies for Glioblastoma. Lim M; Weller M; Chiocca EA Am Soc Clin Oncol Educ Book; 2016; 35():e132-9. PubMed ID: 27249715 [TBL] [Abstract][Full Text] [Related]
15. Therapeutic strategies for inhibiting invasion in glioblastoma. Drappatz J; Norden AD; Wen PY Expert Rev Neurother; 2009 Apr; 9(4):519-34. PubMed ID: 19344303 [TBL] [Abstract][Full Text] [Related]
16. Novel approaches and mechanisms of immunotherapy for glioblastoma. Hegde M; Bielamowicz KJ; Ahmed N Discov Med; 2014 Mar; 17(93):145-54. PubMed ID: 24641957 [TBL] [Abstract][Full Text] [Related]
17. The search for novel therapeutic strategies in the treatment of recurrent glioblastoma multiforme. Bambury RM; Morris PG Expert Rev Anticancer Ther; 2014 Aug; 14(8):955-64. PubMed ID: 24814143 [TBL] [Abstract][Full Text] [Related]
18. How We Treat Recurrent Glioblastoma Today and Current Evidence. Chaul-Barbosa C; Marques DF Curr Oncol Rep; 2019 Oct; 21(10):94. PubMed ID: 31606796 [TBL] [Abstract][Full Text] [Related]